352 related articles for article (PubMed ID: 26703239)
1. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
2. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study.
Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ
Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455
[TBL] [Abstract][Full Text] [Related]
3. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis.
Klimczak-Tomaniak D; Roest S; Brugts JJ; Caliskan K; Kardys I; Zijlstra F; Constantinescu AA; Voermans JJC; van Kampen JJA; Manintveld OC
Transplantation; 2020 Jul; 104(7):1508-1518. PubMed ID: 31644496
[TBL] [Abstract][Full Text] [Related]
5. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
Mahle WT; Fourshee MT; Naftel DM; Alejos JC; Caldwell RL; Uzark K; Berg A; Kanter KR;
J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
[TBL] [Abstract][Full Text] [Related]
6. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
[TBL] [Abstract][Full Text] [Related]
7. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients.
Ponz de Antonio I; Rodríguez Chaverri A; García Reyne A; Carrasco Antón N; Lora Pablos D; López Medrano F; de Dios S; Jurado A; Folgueira MD; García-Cosio Carmena MD; Arribas Ynsaurriaga F; Aguado JM; Lumbreras C; Delgado Jiménez JF
Transpl Infect Dis; 2021 Apr; 23(2):e13479. PubMed ID: 32996216
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Donor Seropositivity Negatively Affects Survival After Heart Transplantation.
Heim C; Müller PP; Tandler R; Cherikh WS; Toll AE; Stehlik J; Weyand M; Khush KK; Ensminger SM
Transplantation; 2022 Jun; 106(6):1243-1252. PubMed ID: 34560698
[TBL] [Abstract][Full Text] [Related]
11. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: effect of preemptive therapy.
Mendez-Eirin E; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Grille-Cancela Z; Cañizares A; Naya-Leira C; Gargallo-Fernández P; Castro-Beiras A; Crespo-Leiro M
Transplant Proc; 2012 Nov; 44(9):2660-2. PubMed ID: 23146486
[TBL] [Abstract][Full Text] [Related]
12. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in heart transplantation: A single center experience.
Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.
Potena L; Grigioni F; Magnani G; Lazzarotto T; Musuraca AC; Ortolani P; Coccolo F; Fallani F; Russo A; Branzi A
J Heart Lung Transplant; 2009 May; 28(5):461-7. PubMed ID: 19416774
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection after kidney transplantation and long-term graft loss.
López-Oliva MO; Flores J; Madero R; Escuin F; Santana MJ; Bellón T; Selgas R; Jiménez C
Nefrologia; 2017; 37(5):515-525. PubMed ID: 28946964
[TBL] [Abstract][Full Text] [Related]
18. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
[TBL] [Abstract][Full Text] [Related]
19. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
